Adjunctive therapies in Kawasaki disease.

ABSTRACT: Despite the administration of intravenous immunoglobulin (IVIg) at a dose of 2 g/kg, approximately 3-5% of children with acute Kawasaki disease (KD) may develop coronary artery aneurysms. IVIg-resistance, defined as recrudescence of fever more than 36 h after IVIg completion, is a risk factor for coronary artery abnormalities. Thus, several adjunctive therapies are being evaluated for use in IVIg-resistant KD patients and in patients with coronary artery abnormalities. In this review the role of some of these adjunctive therapies in treatment of children with KD is discussed.

SUBMITTER: Tremoulet AH 

PROVIDER: S-EPMC5777888 | biostudies-literature | 2018 Jan

REPOSITORIES: biostudies-literature